We also found that heterozygous deletion of MEG3 occurred more frequent than heterozygous amplification in gliomas; mRNA expression of MEG3 was significantly positively correlated with its CNV in both GBM and LGG groups. This evidence concerns the gene MEG3 and glioblastoma.